Brain-Gen Biotech
Records under this name other than patents Brain-Gen Biotech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Brain-Gen Biotech
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,776,817 | Neuregulins for Prevention and Treatment of Damage from Acute Assault on Vascular and Neuronal Tissue and as Regulators of Neuronal Stem Cell Migration Lapsed on the fee record Ended Aug 17, 2022 · High confidence | Lapsed on the fee record | Ended Aug 17, 2022 | High confidence |
| US 8,785,369 | Neuregulins for Prevention and Treatment of Damage from Acute Assault on Vascular and Neuronal Tissue and as Regulators of Neuronal Stem Cell Migration Lapsed on the fee record Ended Jul 22, 2022 · Medium confidence | Lapsed on the fee record | Ended Jul 22, 2022 | Medium confidence |
| US 8,748,131 | Chimeric neuregulins and method of making and use thereof Lapsed on the fee record Ended Jun 10, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2022 | From the USPTO record |
| US 8,008,249 | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration Lapsed on the fee record Ended Aug 30, 2019 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2019 | From the USPTO record |
| US 7,973,007 | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration Lapsed on the fee record Ended Jul 5, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 5, 2019 | From the USPTO record |
| US 8,933,034 | Chimeric Neuregulins and Method of Making and Use Thereof Lapsed on the fee record Ended Jan 13, 2019 · Low confidence | Lapsed on the fee record | Ended Jan 13, 2019 | Low confidence |
| US 8,927,483 | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration Lapsed on the fee record Ended Jan 6, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jan 6, 2019 | From the USPTO record |
| US 8,791,067 | Composition and Method for Reducing Tissue Damage from Inflammatory Disorder or Pathogenic Infection Lapsed on the fee record Ended Jul 29, 2018 · High confidence | Lapsed on the fee record | Ended Jul 29, 2018 | High confidence |